Update 21, 536551
In other words, the FDA BPC-157 vote changed the strength of the recommendation, not the substances legal status by itself
Paul Hetrick, PharmD Published: Mar 27, 2025 Key takeaway: If Wegovy is too expensive, unavailable, or not the right fit, several strong alternatives exist including tirzepatide (Zepbound), oral semaglutide, and non-GLP-1 medications
Building on your GLP-1 experience can make it easier to include nutrients like B12 and NAD+ in your health plan while staying within your providers guidance
This has been shown to result in decreased production of pro-inflammatory cytokines such as Tumor Necrosis Factor alpha (TNF-), interleukin 6 (IL-6), interleukin 8 (IL-8), and interferon gamma (IFN-), and inflammation markers such as cyclooxygenase 2 (COX2) 26,45